Correlation Between Quest PharmaTech and Wilmington Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Wilmington Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Wilmington Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Wilmington Capital Management, you can compare the effects of market volatilities on Quest PharmaTech and Wilmington Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Wilmington Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Wilmington Capital.

Diversification Opportunities for Quest PharmaTech and Wilmington Capital

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Quest and Wilmington is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Wilmington Capital Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wilmington Capital and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Wilmington Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wilmington Capital has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Wilmington Capital go up and down completely randomly.

Pair Corralation between Quest PharmaTech and Wilmington Capital

Assuming the 90 days horizon Quest PharmaTech is expected to generate 3.12 times more return on investment than Wilmington Capital. However, Quest PharmaTech is 3.12 times more volatile than Wilmington Capital Management. It trades about 0.06 of its potential returns per unit of risk. Wilmington Capital Management is currently generating about 0.03 per unit of risk. If you would invest  5.00  in Quest PharmaTech on September 14, 2024 and sell it today you would lose (2.00) from holding Quest PharmaTech or give up 40.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Quest PharmaTech  vs.  Wilmington Capital Management

 Performance 
       Timeline  
Quest PharmaTech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Quest PharmaTech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Quest PharmaTech showed solid returns over the last few months and may actually be approaching a breakup point.
Wilmington Capital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Wilmington Capital Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Quest PharmaTech and Wilmington Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quest PharmaTech and Wilmington Capital

The main advantage of trading using opposite Quest PharmaTech and Wilmington Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Wilmington Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wilmington Capital will offset losses from the drop in Wilmington Capital's long position.
The idea behind Quest PharmaTech and Wilmington Capital Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets